PURR-07

PURR-07 is an investigational veterinary drug candidate being developed by The Cat Health Company as part of its pipeline of longevity medicines for senior cats. The therapeutic is designed to address age-related decline and associated pathologies, specifically targeting indications such as sarcopenia (muscle wasting), chronic kidney disease (CKD), and neurodegeneration. The Cat Health Company focuses on interventions that target the biological drivers of aging to extend the healthy lifespan of feline companions. While PURR-07 is a distinct candidate within the company's 'PURR' series, specific details regarding its molecular target, modality (e.g., small molecule or biologic), and precise clinical development phase have not been publicly disclosed beyond its inclusion in the company's active development pipeline.